During the last session, Bionano Genomics Inc (NASDAQ:BNGO)’s traded shares were 85261.0, with the beta value of the company hitting 2.13. The 52-week high for
Bionano Genomics Inc (NASDAQ:BNGO)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 2.05. At the close of
Bionano Genomics Inc (NASDAQ:BNGO)’s traded shares stood at 1.67 million during the last session, with the company’s beta value hitting 2.39. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
